Short answer
Most people regain much of the weight, so these are usually long-term medications.
In the STEP 1 trial extension, participants regained about two-thirds of their lost weight within a year of stopping semaglutide. Researchers describe this as evidence that obesity is a chronic condition that usually needs ongoing treatment to maintain the result. The honest implication is to treat a GLP-1 as a long-term medication when you start, which makes the cost and coverage questions worth planning early, alongside your doctor.
Start here
What you actually came to find out
Plain answers first. Sources stay below for checking details.
Do you regain weight after stopping?
Yes. The main trial saw about two-thirds regained within a year.
Why does that happen?
Researchers treat obesity as a chronic condition needing ongoing treatment.
Does that mean it failed?
No. It means the result is maintained by staying on, like other chronic conditions.
What should I plan for?
Treat it as a long-term medication, including the cost.
Weight regain
About two-thirds
The STEP 1 extension saw about two-thirds of lost weight regained within a year of stopping.
Source trail: Diabetes, Obesity and Metabolism
Why
Chronic condition
Researchers describe obesity as a chronic condition needing ongoing treatment.
Source trail: Diabetes, Obesity and Metabolism
Implication
Long-term
The result is usually maintained only by continuing the medication.
Source trail: Diabetes, Obesity and Metabolism
Plan for
Cost too
A long-term medication makes coverage and cost worth planning early.
Source trail: Diabetes, Obesity and Metabolism
The straight answer is that stopping tends to reverse the result, so the real decision at the start is whether this is a long-term plan, in both health and budget terms.
Neutral landscape
The shape of the question
The STEP 1 extension is the main source because it measured weight change after stopping the drug.
Source trail: Diabetes, Obesity and Metabolism
The framing matters, since researchers describe obesity as a chronic condition that needs ongoing treatment.
Source trail: Diabetes, Obesity and Metabolism
The implication is practical: plan for a GLP-1 as a long-term medication, not a short course.
Source trail: Diabetes, Obesity and Metabolism
The cost angle follows, because a long-term medication makes coverage and budgeting worth planning early.
Source trail: Diabetes, Obesity and Metabolism
Curator core
What the authorities say
These sources are here for the reader who wants to check the work. The plain-English answer stays above them.
Source 01
Diabetes, Obesity and Metabolism
STEP 1 Trial Extension: Weight Change After Stopping
The STEP 1 trial extension followed participants after they stopped semaglutide to measure weight regain.
Source framing
The STEP 1 extension found participants regained about two-thirds of their lost weight within a year of stopping semaglutide, which researchers describe as evidence obesity needs ongoing treatment.
Strongest for: what research shows about weight regain after stopping
Read at Diabetes, Obesity and MetabolismPlain-English forks
The forks people face
Most retirement questions hide a few smaller decisions. These are the practical pieces that change the plan.
Is this a long-term plan for you?
Why it matters: Stopping tends to reverse the result.
In real life: This fork is the core decision.
What to look at: What to look at: the continuation plan with your doctor.
Can you sustain the cost?
Why it matters: A long-term medication is a recurring expense.
In real life: This fork is the budget side.
What to look at: What to look at: our GLP-1 cost and coverage pages.
Are you pairing it with habits?
Why it matters: Exercise and nutrition support the result while you are on it.
In real life: This fork supports the health side.
What to look at: What to look at: a strength and nutrition plan.
Common questions
Quick answers
Short, plain answers for the questions people usually have next. The source trail stays available below.
Will I regain weight if I stop a GLP-1?+
Research suggests yes. In the STEP 1 trial extension, participants regained about two-thirds of their lost weight within a year of stopping semaglutide.
Why is the weight regained?+
Researchers describe obesity as a chronic condition, so the improvements are usually maintained only with ongoing treatment.
Does that mean the drug did not work?+
No. It means the result is maintained by staying on the medication, the way many chronic conditions are managed long term.
What should I plan for before starting?+
Plan for a GLP-1 as a long-term medication, including the recurring cost and how it is covered. Our cost and coverage pages can help.
Can I ever stop?+
That is a medical decision for you and your doctor. The research simply shows that stopping tends to reverse the weight loss.
How this page is curated
This page uses the STEP 1 trial extension. It is factual information, not medical advice, and it draws the planning implication that a GLP-1 is usually a long-term medication.
Read the planner methodologyTrust anchor
Sources used on this page
Every source named above is listed here in one place.
Diabetes, Obesity and Metabolism. STEP 1 Trial Extension: Weight Change After Stopping
https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14725
Before you act on this
This plan is educational. It is not personalized financial, tax, or insurance advice. Projections illustrate the math, they do not predict the future. Talk to your own licensed financial professional before acting on any of it.